益诺思

688710 SSE 证监会行业分类 M73研究和试验发展

Key Metrics

Market Cap

7.3B ($1.1B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

1.1B

Net Income

137.0M

Gross Margin

N/A

Op. Margin

13.9%

Net Margin

12.0%

ROE

5.7%

ROA

4.3%

D/E

0.34

Dividend Yield

N/A

EPS

1.26

Current Ratio

3.82

Price History

Company Info

Industry	M73研究和试验发展
Market Segment	STAR Market
Currency	CNY
Fiscal Year	2024

Business Overview

Shanghai InnoStar Bio-tech Co., Ltd. provides drug research and development services in China and internationally. The company offers screening and discovery, nonclinical assessment stage, and clinical development stage services in the areas of chemical products, biologics, cell and gene therapeutics, radiopharmaceuticals, and traditional Chinese medicines. The company was founded in 2010 and is based in Shanghai, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 益诺思

Ticker	688710
Exchange	SSE
Sector	证监会行业分类
Industry	M73研究和试验发展